Literature DB >> 22438288

Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function.

Andreina Pauli1, Diana P Prata, Andrea Mechelli, Marco Picchioni, Cynthia H Y Fu, Christopher A Chaddock, Fergus Kane, Sridevi Kalidindi, Colm McDonald, Eugenia Kravariti, Timothea Toulopoulou, Elvira Bramon, Muriel Walshe, Natascha Ehlert, Anna Georgiades, Robin Murray, David A Collier, Philip McGuire.   

Abstract

The genes for the dopamine transporter (DAT) and the D-Amino acid oxidase activator (DAOA or G72) have been independently implicated in the risk for schizophrenia and in bipolar disorder and/or their related intermediate phenotypes. DAT and G72 respectively modulate central dopamine and glutamate transmission, the two systems most robustly implicated in these disorders. Contemporary studies have demonstrated that elevated dopamine function is associated with glutamatergic dysfunction in psychotic disorders. Using functional magnetic resonance imaging we examined whether there was an interaction between the effects of genes that influence dopamine and glutamate transmission (DAT and G72) on regional brain activation during verbal fluency, which is known to be abnormal in psychosis, in 80 healthy volunteers. Significant interactions between the effects of G72 and DAT polymorphisms on activation were evident in the striatum, parahippocampal gyrus, and supramarginal/angular gyri bilaterally, the right insula, in the right pre-/postcentral and the left posterior cingulate/retrosplenial gyri (P < 0.05, FDR-corrected across the whole brain). This provides evidence that interactions between the dopamine and the glutamate system, thought to be altered in psychosis, have an impact in executive processing which can be modulated by common genetic variation.
Copyright © 2012 Wiley Periodicals, Inc., a Wiley company.

Entities:  

Keywords:  DAT; epistasis; imaging genetics; psychosis, DAOA/G72; schizophrenia; verbal fluency

Mesh:

Substances:

Year:  2012        PMID: 22438288      PMCID: PMC6869864          DOI: 10.1002/hbm.22061

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  117 in total

1.  Differential activity in left inferior frontal gyrus for pseudowords and real words: an event-related fMRI study on auditory lexical decision.

Authors:  Zhuangwei Xiao; John X Zhang; Xiaoyi Wang; Renhua Wu; Xiaoping Hu; Xuchu Weng; Li Hai Tan
Journal:  Hum Brain Mapp       Date:  2005-06       Impact factor: 5.038

2.  Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness.

Authors:  Päivikki Tanskanen; Khanum Ridler; Graham K Murray; Marianne Haapea; Juha M Veijola; Erika Jääskeläinen; Jouko Miettunen; Peter B Jones; Edward T Bullmore; Matti K Isohanni
Journal:  Schizophr Bull       Date:  2008-11-17       Impact factor: 9.306

Review 3.  Presynaptic regulation of dopamine release. Implications for the functional organization of the basal ganglia.

Authors:  M F Chesselet
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

4.  Cortical thickness reduction in individuals at ultra-high-risk for psychosis.

Authors:  Wi Hoon Jung; June Sic Kim; Joon Hwan Jang; Jung-Seok Choi; Myung Hun Jung; Ji-Young Park; Ji Yeon Han; Chi-Hoon Choi; Do-Hyung Kang; Chun Kee Chung; Jun Soo Kwon
Journal:  Schizophr Bull       Date:  2009-12-21       Impact factor: 9.306

5.  Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization.

Authors:  D A Lewis; D S Melchitzky; S R Sesack; R E Whitehead; S Auh; A Sampson
Journal:  J Comp Neurol       Date:  2001-03-26       Impact factor: 3.215

6.  The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.

Authors:  S Fuke; S Suo; N Takahashi; H Koike; N Sasagawa; S Ishiura
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

Review 7.  The role of the insula in schizophrenia.

Authors:  Korey P Wylie; Jason R Tregellas
Journal:  Schizophr Res       Date:  2010-09-15       Impact factor: 4.939

8.  NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.

Authors:  Georg Northoff; Andre Richter; Felix Bermpohl; Simone Grimm; Ernst Martin; Valentine Leslie Marcar; Constance Wahl; Daniel Hell; Heinz Boeker
Journal:  Schizophr Res       Date:  2005-01-01       Impact factor: 4.939

9.  Negative features, retrieval processes and verbal fluency in schizophrenia.

Authors:  H A Allen; P F Liddle; C D Frith
Journal:  Br J Psychiatry       Date:  1993-12       Impact factor: 9.319

10.  A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe.

Authors:  Andreas Jansen; Sören Krach; Axel Krug; Valentin Markov; Thomas Eggermann; Klaus Zerres; Tony Stöcker; N Jon Shah; Markus M Nöthen; Jens Treutlein; Marcella Rietschel; Tilo Kircher
Journal:  Neuroimage       Date:  2009-01-08       Impact factor: 6.556

View more
  5 in total

Review 1.  Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia: Still promising or a dead end?

Authors:  Meng-Lin Li; Xi-Quan Hu; Feng Li; Wen-Jun Gao
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-24       Impact factor: 5.067

2.  Category fluency, latent semantic analysis and schizophrenia: a candidate gene approach.

Authors:  Kristin K Nicodemus; Brita Elvevåg; Peter W Foltz; Mark Rosenstein; Catherine Diaz-Asper; Daniel R Weinberger
Journal:  Cortex       Date:  2013-12-20       Impact factor: 4.027

3.  Neural Correlates of Set-Shifting in Children With Autism.

Authors:  Benjamin E Yerys; Ligia Antezana; Rachel Weinblatt; Kathryn F Jankowski; John Strang; Chandan J Vaidya; Robert T Schultz; William D Gaillard; Lauren Kenworthy
Journal:  Autism Res       Date:  2015-01-20       Impact factor: 5.216

Review 4.  The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.

Authors:  Ralf Brisch; Arthur Saniotis; Rainer Wolf; Hendrik Bielau; Hans-Gert Bernstein; Johann Steiner; Bernhard Bogerts; Katharina Braun; Anna Katharina Braun; Zbigniew Jankowski; Jaliya Kumaratilake; Jaliya Kumaritlake; Maciej Henneberg; Tomasz Gos
Journal:  Front Psychiatry       Date:  2014-05-19       Impact factor: 4.157

5.  Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment.

Authors:  Jiaen Ye; Feng Ji; Deguo Jiang; Xiaodong Lin; Guangdong Chen; Wei Zhang; Peiwei Shan; Li Zhang; Chuanjun Zhuo
Journal:  Front Neurosci       Date:  2019-04-17       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.